

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.53950696 |
| 2 | positive regulation of mast cell activation (GO:0033005) | 4.45762818 |
| 3 | adenosine receptor signaling pathway (GO:0001973) | 4.26105153 |
| 4 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.12035307 |
| 5 | positive regulation of mast cell degranulation (GO:0043306) | 4.12035307 |
| 6 | response to peptidoglycan (GO:0032494) | 4.01052357 |
| 7 | immunoglobulin mediated immune response (GO:0016064) | 3.90211173 |
| 8 | granulocyte activation (GO:0036230) | 3.89989947 |
| 9 | regulation of mast cell degranulation (GO:0043304) | 3.83762191 |
| 10 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.83397324 |
| 11 | regulation of platelet activation (GO:0010543) | 3.80871822 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 3.80146012 |
| 13 | neutrophil activation (GO:0042119) | 3.77301640 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.61647309 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61432514 |
| 16 | lipoxygenase pathway (GO:0019372) | 3.58885529 |
| 17 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.56695832 |
| 18 | regulation of platelet aggregation (GO:0090330) | 3.50687754 |
| 19 | thrombin receptor signaling pathway (GO:0070493) | 3.49246447 |
| 20 | microglial cell activation (GO:0001774) | 3.42406399 |
| 21 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.36412097 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.34846151 |
| 23 | regulation of mast cell activation (GO:0033003) | 3.34602336 |
| 24 | myeloid cell activation involved in immune response (GO:0002275) | 3.27354655 |
| 25 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.26278109 |
| 26 | positive regulation of leukocyte degranulation (GO:0043302) | 3.25762456 |
| 27 | regulation of leukocyte degranulation (GO:0043300) | 3.21166281 |
| 28 | B cell mediated immunity (GO:0019724) | 3.20382363 |
| 29 | glycosphingolipid catabolic process (GO:0046479) | 3.17484339 |
| 30 | angiogenesis involved in wound healing (GO:0060055) | 3.17186743 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.15612414 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13427182 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.13427182 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13427182 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13427182 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13427182 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.13427182 |
| 38 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11511680 |
| 39 | phagocytosis, engulfment (GO:0006911) | 3.06617210 |
| 40 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.05778233 |
| 41 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.05453093 |
| 42 | negative regulation of platelet activation (GO:0010544) | 3.00251653 |
| 43 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.97457083 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 2.95549646 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91766962 |
| 46 | macrophage activation (GO:0042116) | 2.87860257 |
| 47 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87677316 |
| 48 | detection of other organism (GO:0098543) | 2.86542631 |
| 49 | regulation of hypersensitivity (GO:0002883) | 2.85403887 |
| 50 | glycolipid catabolic process (GO:0019377) | 2.83357993 |
| 51 | regulation of mononuclear cell migration (GO:0071675) | 2.80745861 |
| 52 | positive regulation of type 2 immune response (GO:0002830) | 2.80541717 |
| 53 | purinergic receptor signaling pathway (GO:0035587) | 2.79375869 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78687918 |
| 55 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.78256131 |
| 56 | response to thyroid hormone (GO:0097066) | 2.77376367 |
| 57 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.76607699 |
| 58 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76202832 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75270007 |
| 60 | cyclooxygenase pathway (GO:0019371) | 2.75056534 |
| 61 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.74035176 |
| 62 | cellular extravasation (GO:0045123) | 2.74002787 |
| 63 | low-density lipoprotein particle remodeling (GO:0034374) | 2.73092083 |
| 64 | detection of bacterium (GO:0016045) | 2.72162099 |
| 65 | amino sugar catabolic process (GO:0046348) | 2.70289209 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 2.68194922 |
| 67 | regulation of antigen processing and presentation (GO:0002577) | 2.67409653 |
| 68 | leukocyte degranulation (GO:0043299) | 2.66500337 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.66055967 |
| 70 | positive regulation of macrophage differentiation (GO:0045651) | 2.64938649 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64711179 |
| 72 | germinal center formation (GO:0002467) | 2.64139931 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63739816 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.63715453 |
| 75 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.63210527 |
| 76 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.61922624 |
| 77 | positive regulation of B cell mediated immunity (GO:0002714) | 2.61922624 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.61462963 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.61462963 |
| 80 | detection of external biotic stimulus (GO:0098581) | 2.60427660 |
| 81 | negative regulation of interleukin-17 production (GO:0032700) | 2.60389309 |
| 82 | T-helper 1 type immune response (GO:0042088) | 2.59530086 |
| 83 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.59136199 |
| 84 | membrane invagination (GO:0010324) | 2.58920349 |
| 85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.58873179 |
| 86 | superoxide anion generation (GO:0042554) | 2.58741464 |
| 87 | platelet aggregation (GO:0070527) | 2.57054325 |
| 88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.56815226 |
| 89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.56686068 |
| 90 | response to host immune response (GO:0052572) | 2.56686068 |
| 91 | pinocytosis (GO:0006907) | 2.55898687 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55619817 |
| 93 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.55518191 |
| 94 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.54310094 |
| 95 | ceramide catabolic process (GO:0046514) | 2.54234680 |
| 96 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.52940050 |
| 97 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.52468203 |
| 98 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.51966199 |
| 99 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51657312 |
| 100 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.51285780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.49781497 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25844750 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88226121 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.57980020 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37902568 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.35161054 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14661461 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02594317 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89392234 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88928433 |
| 11 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.88355476 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84837859 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.82844158 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74039090 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.50041245 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50034057 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33270617 |
| 18 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.31528270 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29770327 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24793392 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14869290 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.10879762 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 2.07682711 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03573426 |
| 25 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.96036547 |
| 26 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93036711 |
| 27 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.92536451 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87461458 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86750862 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86737714 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83963778 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83190495 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80283792 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77680179 |
| 35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74874422 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72409575 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70993732 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70413286 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68911763 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61629929 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60512341 |
| 42 | GATA2_19941826_ChIP-Seq_K562_Human | 1.57457530 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57270284 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56785485 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55864623 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51010362 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.40421663 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40133831 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37867247 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30459291 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29243760 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26040148 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26017186 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24118388 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.22962095 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22004841 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21629332 |
| 58 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20915270 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19921611 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18807011 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17315124 |
| 62 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.16501059 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16362936 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15981530 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.15007121 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14575069 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12386396 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11818460 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09889146 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08451046 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08138242 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07211638 |
| 73 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04697146 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01456414 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01380460 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98866606 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98670931 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95342011 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94648174 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92396885 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89200390 |
| 82 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.87366932 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85951780 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85789946 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85351864 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.85317187 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84263209 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 0.83972780 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83820607 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81754431 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81749859 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.81035713 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79850997 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78155827 |
| 95 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78020438 |
| 96 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.77420024 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77309088 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.77134739 |
| 99 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75775344 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75241303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 4.84126675 |
| 2 | MP0003303_peritoneal_inflammation | 4.52315824 |
| 3 | MP0003724_increased_susceptibility_to | 3.93289573 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.83588150 |
| 5 | MP0008004_abnormal_stomach_pH | 3.49133418 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.07468195 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.04376034 |
| 8 | MP0003436_decreased_susceptibility_to | 2.84147692 |
| 9 | MP0004510_myositis | 2.82418438 |
| 10 | MP0006082_CNS_inflammation | 2.75512899 |
| 11 | MP0005671_abnormal_response_to | 2.57910494 |
| 12 | MP0000343_altered_response_to | 2.55662836 |
| 13 | MP0002419_abnormal_innate_immunity | 2.47041010 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.40115272 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.27143685 |
| 16 | MP0009785_altered_susceptibility_to | 2.25920828 |
| 17 | MP0005025_abnormal_response_to | 2.23372317 |
| 18 | MP0001790_abnormal_immune_system | 2.18238630 |
| 19 | MP0005387_immune_system_phenotype | 2.18238630 |
| 20 | MP0003075_altered_response_to | 2.17258468 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 2.12814535 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.06973543 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 2.04843172 |
| 24 | MP0009764_decreased_sensitivity_to | 2.00610841 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.99612686 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.99394759 |
| 27 | MP0002723_abnormal_immune_serum | 1.95167091 |
| 28 | MP0001545_abnormal_hematopoietic_system | 1.94103511 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.94103511 |
| 30 | MP0001800_abnormal_humoral_immune | 1.86959373 |
| 31 | MP0009840_abnormal_foam_cell | 1.80433605 |
| 32 | MP0009278_abnormal_bone_marrow | 1.77799103 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.73902607 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.68676721 |
| 35 | MP0001819_abnormal_immune_cell | 1.68098520 |
| 36 | MP0003828_pulmonary_edema | 1.62762134 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.58684001 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.57502227 |
| 39 | MP0000685_abnormal_immune_system | 1.57409780 |
| 40 | MP0004947_skin_inflammation | 1.55591414 |
| 41 | MP0003690_abnormal_glial_cell | 1.37459129 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.34774334 |
| 43 | MP0000858_altered_metastatic_potential | 1.31256292 |
| 44 | MP0002405_respiratory_system_inflammati | 1.31081767 |
| 45 | MP0008469_abnormal_protein_level | 1.29066273 |
| 46 | MP0001851_eye_inflammation | 1.26458165 |
| 47 | MP0002398_abnormal_bone_marrow | 1.26379928 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.26158934 |
| 49 | MP0000604_amyloidosis | 1.25841973 |
| 50 | MP0005165_increased_susceptibility_to | 1.24542585 |
| 51 | MP0000716_abnormal_immune_system | 1.23405561 |
| 52 | MP0005166_decreased_susceptibility_to | 1.22521764 |
| 53 | MP0003448_altered_tumor_morphology | 1.21033496 |
| 54 | MP0006054_spinal_hemorrhage | 1.15239680 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.14551655 |
| 56 | MP0009763_increased_sensitivity_to | 1.13497009 |
| 57 | MP0001663_abnormal_digestive_system | 1.11454050 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.08596695 |
| 59 | MP0001853_heart_inflammation | 1.08154332 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.07840461 |
| 61 | MP0000249_abnormal_blood_vessel | 1.07085947 |
| 62 | MP0005310_abnormal_salivary_gland | 1.06644540 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.06121232 |
| 64 | MP0002429_abnormal_blood_cell | 1.06115072 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.05654354 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.99113639 |
| 67 | MP0004130_abnormal_muscle_cell | 0.97534932 |
| 68 | MP0000230_abnormal_systemic_arterial | 0.94847224 |
| 69 | MP0003879_abnormal_hair_cell | 0.93848648 |
| 70 | MP0008874_decreased_physiological_sensi | 0.93577835 |
| 71 | MP0005666_abnormal_adipose_tissue | 0.92318836 |
| 72 | MP0002722_abnormal_immune_system | 0.91510318 |
| 73 | MP0005365_abnormal_bile_salt | 0.89564834 |
| 74 | MP0005535_abnormal_body_temperature | 0.88771733 |
| 75 | MP0002332_abnormal_exercise_endurance | 0.88680316 |
| 76 | MP0000920_abnormal_myelination | 0.86627759 |
| 77 | MP0003638_abnormal_response/metabolism_ | 0.84819519 |
| 78 | MP0005390_skeleton_phenotype | 0.82269660 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.81869918 |
| 80 | MP0005647_abnormal_sex_gland | 0.78914029 |
| 81 | MP0005164_abnormal_response_to | 0.76639957 |
| 82 | MP0008260_abnormal_autophagy | 0.76619943 |
| 83 | MP0005451_abnormal_body_composition | 0.75761851 |
| 84 | MP0003866_abnormal_defecation | 0.75655138 |
| 85 | MP0004883_abnormal_blood_vessel | 0.74124648 |
| 86 | MP0005083_abnormal_biliary_tract | 0.73605632 |
| 87 | MP0003795_abnormal_bone_structure | 0.71230528 |
| 88 | MP0004084_abnormal_cardiac_muscle | 0.68903365 |
| 89 | MP0005410_abnormal_fertilization | 0.68820849 |
| 90 | MP0003186_abnormal_redox_activity | 0.67208088 |
| 91 | MP0005670_abnormal_white_adipose | 0.66007775 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65823136 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.65586729 |
| 94 | MP0005023_abnormal_wound_healing | 0.65051303 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.64859896 |
| 96 | MP0001542_abnormal_bone_strength | 0.64551237 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.62170324 |
| 98 | MP0002132_abnormal_respiratory_system | 0.59059880 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.58135170 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.57619673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 6.51720026 |
| 2 | Purpura (HP:0000979) | 6.41459344 |
| 3 | Petechiae (HP:0000967) | 6.24624541 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.06513131 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.06513131 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.06513131 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.01643284 |
| 8 | Epistaxis (HP:0000421) | 4.95940720 |
| 9 | Menorrhagia (HP:0000132) | 4.94827057 |
| 10 | Increased mean platelet volume (HP:0011877) | 4.94765770 |
| 11 | Abnormal platelet volume (HP:0011876) | 4.88053424 |
| 12 | Spontaneous hematomas (HP:0007420) | 4.57796383 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.45779471 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.34593325 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.33746578 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 4.18436903 |
| 17 | Gingival bleeding (HP:0000225) | 4.03866315 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.77789806 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.69013854 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.61870596 |
| 21 | Eczematoid dermatitis (HP:0000976) | 3.53792195 |
| 22 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.50506861 |
| 23 | Stomatitis (HP:0010280) | 3.49422205 |
| 24 | Disinhibition (HP:0000734) | 3.44926043 |
| 25 | Mutism (HP:0002300) | 3.29709589 |
| 26 | Loss of speech (HP:0002371) | 3.27450710 |
| 27 | Abnormal platelet function (HP:0011869) | 3.23104648 |
| 28 | Impaired platelet aggregation (HP:0003540) | 3.23104648 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.23088641 |
| 30 | Obstructive lung disease (HP:0006536) | 3.13834400 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13834400 |
| 32 | Glomerulonephritis (HP:0000099) | 3.06771082 |
| 33 | Hepatosplenomegaly (HP:0001433) | 3.06212984 |
| 34 | Myositis (HP:0100614) | 2.95741849 |
| 35 | Conjunctival telangiectasia (HP:0000524) | 2.94687211 |
| 36 | Orchitis (HP:0100796) | 2.90238545 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 2.80068359 |
| 38 | Axonal loss (HP:0003447) | 2.79711847 |
| 39 | Optic neuritis (HP:0100653) | 2.76315884 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.76315884 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.73917838 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68717376 |
| 43 | Complement deficiency (HP:0004431) | 2.62518224 |
| 44 | Abnormality of lateral ventricle (HP:0030047) | 2.58417647 |
| 45 | Increased serum ferritin (HP:0003281) | 2.58012236 |
| 46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57263628 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57263628 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57263628 |
| 49 | Abnormality of iron homeostasis (HP:0011031) | 2.46527850 |
| 50 | Amyloidosis (HP:0011034) | 2.46470245 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.45979814 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44360072 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.44360072 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.44021518 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41223499 |
| 56 | Increased IgM level (HP:0003496) | 2.33771180 |
| 57 | Encephalitis (HP:0002383) | 2.29922001 |
| 58 | Myocardial infarction (HP:0001658) | 2.25854996 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25312860 |
| 60 | Recurrent skin infections (HP:0001581) | 2.19372582 |
| 61 | Vertigo (HP:0002321) | 2.19269844 |
| 62 | Nausea (HP:0002018) | 2.18694587 |
| 63 | Meningitis (HP:0001287) | 2.16413396 |
| 64 | Nuclear cataract (HP:0100018) | 2.14826923 |
| 65 | Vasculitis (HP:0002633) | 2.13711561 |
| 66 | Bruising susceptibility (HP:0000978) | 2.10907952 |
| 67 | Abnormality of complement system (HP:0005339) | 2.10625944 |
| 68 | Arterial thrombosis (HP:0004420) | 2.09319994 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.08604784 |
| 70 | Hematochezia (HP:0002573) | 2.06074183 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.05205503 |
| 72 | Pulmonary embolism (HP:0002204) | 2.03718953 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.03454648 |
| 74 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.03226795 |
| 75 | Paralysis (HP:0003470) | 2.02642310 |
| 76 | Hemoptysis (HP:0002105) | 2.02594641 |
| 77 | Keratoconjunctivitis sicca (HP:0001097) | 2.01084170 |
| 78 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00340580 |
| 79 | Joint hemorrhage (HP:0005261) | 1.98884272 |
| 80 | Episodic fever (HP:0001954) | 1.97884459 |
| 81 | Polyneuropathy (HP:0001271) | 1.96240233 |
| 82 | Gingivitis (HP:0000230) | 1.94048383 |
| 83 | Chest pain (HP:0100749) | 1.93699246 |
| 84 | Joint swelling (HP:0001386) | 1.93489996 |
| 85 | Progressive neurologic deterioration (HP:0002344) | 1.90885916 |
| 86 | Agnosia (HP:0010524) | 1.90832263 |
| 87 | Gangrene (HP:0100758) | 1.89651496 |
| 88 | Neuronal loss in central nervous system (HP:0002529) | 1.88705102 |
| 89 | Thrombocytosis (HP:0001894) | 1.87539138 |
| 90 | Abnormality of the prostate (HP:0008775) | 1.87374077 |
| 91 | Leukocytosis (HP:0001974) | 1.86461069 |
| 92 | Urticaria (HP:0001025) | 1.83819896 |
| 93 | Mucosal telangiectasiae (HP:0100579) | 1.81638239 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 1.80832960 |
| 95 | Ventricular fibrillation (HP:0001663) | 1.80705038 |
| 96 | Apathy (HP:0000741) | 1.80454521 |
| 97 | Diminished motivation (HP:0000745) | 1.80259375 |
| 98 | Nephritis (HP:0000123) | 1.80169275 |
| 99 | Keratoconjunctivitis (HP:0001096) | 1.79666063 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 1.78418465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.54429151 |
| 2 | BLK | 3.33814519 |
| 3 | CSF1R | 2.32606436 |
| 4 | IRAK3 | 2.32516421 |
| 5 | PIM2 | 2.23687952 |
| 6 | MAP2K3 | 2.18514384 |
| 7 | BMX | 2.15715681 |
| 8 | SYK | 2.11501184 |
| 9 | TAOK2 | 2.10974153 |
| 10 | TEC | 2.06655993 |
| 11 | BTK | 2.06232280 |
| 12 | MAP3K11 | 2.04547637 |
| 13 | GRK7 | 1.95467531 |
| 14 | ZAP70 | 1.92305560 |
| 15 | FES | 1.88908184 |
| 16 | FGR | 1.88879353 |
| 17 | MAP4K1 | 1.85659118 |
| 18 | BMPR2 | 1.84077312 |
| 19 | MAP3K14 | 1.82632775 |
| 20 | TAOK3 | 1.80450755 |
| 21 | TBK1 | 1.78829418 |
| 22 | IKBKB | 1.74200166 |
| 23 | MAP3K3 | 1.69080656 |
| 24 | TGFBR2 | 1.68964360 |
| 25 | MATK | 1.68929004 |
| 26 | CSK | 1.68136532 |
| 27 | TAOK1 | 1.62030525 |
| 28 | TYK2 | 1.60643700 |
| 29 | NME2 | 1.58588040 |
| 30 | TNK2 | 1.57228408 |
| 31 | ARAF | 1.54606002 |
| 32 | MYLK | 1.51079213 |
| 33 | ERN1 | 1.50462014 |
| 34 | LYN | 1.45054187 |
| 35 | TXK | 1.44231228 |
| 36 | DDR2 | 1.38530213 |
| 37 | JAK3 | 1.35010246 |
| 38 | IRAK4 | 1.32993334 |
| 39 | ADRBK2 | 1.27890884 |
| 40 | TESK2 | 1.27304275 |
| 41 | HCK | 1.26309575 |
| 42 | ACVR1B | 1.06756803 |
| 43 | GRK5 | 1.06469842 |
| 44 | GRK6 | 1.06278088 |
| 45 | ABL2 | 1.06139920 |
| 46 | MAP3K5 | 1.06070376 |
| 47 | PIK3CG | 1.05961109 |
| 48 | IKBKE | 1.03985186 |
| 49 | MAP3K1 | 1.01672466 |
| 50 | MST4 | 1.01500163 |
| 51 | KIT | 1.00185713 |
| 52 | CAMKK2 | 0.99211116 |
| 53 | PRPF4B | 0.98927354 |
| 54 | PTK2B | 0.96913271 |
| 55 | JAK2 | 0.95527237 |
| 56 | EIF2AK1 | 0.92877938 |
| 57 | LCK | 0.90905357 |
| 58 | DAPK2 | 0.90587437 |
| 59 | RIPK1 | 0.89383423 |
| 60 | DAPK3 | 0.86446380 |
| 61 | CDC42BPA | 0.85192997 |
| 62 | ITK | 0.83707643 |
| 63 | JAK1 | 0.80817350 |
| 64 | MOS | 0.80136694 |
| 65 | IRAK1 | 0.79437984 |
| 66 | PKN1 | 0.77000501 |
| 67 | MARK3 | 0.75180359 |
| 68 | MAPK12 | 0.71560079 |
| 69 | MAP3K13 | 0.70563222 |
| 70 | PDK1 | 0.69274512 |
| 71 | PDPK1 | 0.64165739 |
| 72 | IRAK2 | 0.62818351 |
| 73 | MAPKAPK3 | 0.61348874 |
| 74 | PAK1 | 0.56324572 |
| 75 | ILK | 0.55485451 |
| 76 | PRKD1 | 0.52896439 |
| 77 | MAPK4 | 0.51160080 |
| 78 | PIM1 | 0.49839143 |
| 79 | FYN | 0.47283039 |
| 80 | SIK3 | 0.44396180 |
| 81 | EPHA3 | 0.41216088 |
| 82 | PRKACG | 0.39965500 |
| 83 | KDR | 0.39154132 |
| 84 | ABL1 | 0.37234090 |
| 85 | PRKCD | 0.37156019 |
| 86 | MAP2K6 | 0.36198700 |
| 87 | ADRBK1 | 0.35342975 |
| 88 | DMPK | 0.35096935 |
| 89 | TESK1 | 0.34985198 |
| 90 | PRKCQ | 0.34554492 |
| 91 | STK24 | 0.33007682 |
| 92 | MAPK7 | 0.32648469 |
| 93 | DYRK1B | 0.32243612 |
| 94 | EPHB2 | 0.31564416 |
| 95 | RET | 0.31335005 |
| 96 | RPS6KL1 | 0.30295727 |
| 97 | RPS6KC1 | 0.30295727 |
| 98 | HIPK2 | 0.30233249 |
| 99 | CDK6 | 0.28689026 |
| 100 | BCKDK | 0.27746402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.44790189 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.23411843 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.70816047 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54836014 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.45629805 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45377416 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41206198 |
| 8 | Platelet activation_Homo sapiens_hsa04611 | 2.39648691 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.38341862 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32235888 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.23612896 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22916503 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.19155154 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07073625 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97351227 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.93202839 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92263673 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.88063700 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78272696 |
| 20 | Phagosome_Homo sapiens_hsa04145 | 1.73140557 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.65736671 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49187972 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48409511 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46315702 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44764239 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39900391 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39475618 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.38652982 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34696957 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.24372027 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22903474 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19707841 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.19562482 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15420815 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14429043 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13327347 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12441490 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10967088 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10642184 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.05690699 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03253608 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.02223531 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01823738 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01621424 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97455907 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96636015 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95910608 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91909650 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90348192 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.88214155 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.86908461 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84852483 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.84290681 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83438556 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.82430301 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78923501 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77151875 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74554014 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73671710 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73287391 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72968783 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.72560969 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.68692654 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67742050 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.66959435 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65967887 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63501830 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63442345 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60359197 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.58163473 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57409018 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56936984 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.56173936 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55556045 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55337953 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51305202 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48070712 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45829976 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44366477 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43970445 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.40997820 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.39492066 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39144393 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37064654 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36353381 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33484403 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32587173 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.32540914 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30241094 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29777361 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29558573 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.29253922 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28846970 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25560240 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25188617 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25120557 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21659348 |
| 98 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.21371814 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20238449 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20115525 |

